Galectin Therapeutics Inc.

NasdaqCM:GALT Stock Report

Market Cap: US$339.5m

Galectin Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:GALT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Jul 25BuyUS$2,925Kary EldredIndividual1,000US$2.93
17 Jul 25BuyUS$14,495Kevin FreemanIndividual5,000US$2.90
30 Dec 24BuyUS$7,540Harold ShlevinIndividual6,500US$1.16
24 Dec 24BuyUS$8,134Kevin FreemanIndividual10,000US$0.81
24 Dec 24BuyUS$11,045Kary EldredIndividual13,469US$0.82
24 Dec 24BuyUS$8,164Richard ZordaniIndividual10,000US$0.82

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GALT?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds5,922,2079.24%
Institutions10,975,38117.1%
Individual Insiders13,152,68820.5%
General Public34,009,98653.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 43.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.1%
Richard Uihlein
10,338,981US$54.8m0%no data
9.24%
10x Capital Management, LLC
5,922,207US$31.4m0%100.0%
3.41%
The Vanguard Group, Inc.
2,184,548US$11.6m-0.36%no data
1.96%
Osaic Wealth, Inc.
1,255,384US$6.7m3.46%0.01%
1.63%
James Czirr
1,045,541US$5.5m36.7%no data
1.39%
BlackRock, Inc.
891,879US$4.7m-37%no data
1.3%
Joel Lewis
834,592US$4.4m0%no data
1.06%
Jane Street Group, LLC
680,919US$3.6m0%0.01%
1.04%
Geode Capital Management, LLC
666,191US$3.5m-21.9%no data
0.78%
Kary Eldred
500,634US$2.7m0.2%no data
0.75%
Wealthspire Advisors LLC
479,518US$2.5m20.4%0.01%
0.66%
Geneos Wealth Management, Inc.
423,235US$2.2m0%0.05%
0.57%
LPL Financial LLC
366,978US$1.9m89.7%no data
0.45%
Commonwealth Equity Services, LLC
285,414US$1.5m10.8%no data
0.38%
Cross Consulting and Services, LLC
243,745US$1.3m0%no data
0.37%
Y-Intercept (Hong Kong) Limited
235,192US$1.2m0%0.07%
0.32%
Morgan Stanley
203,943US$1.1m-7.08%no data
0.31%
State Street Global Advisors, Inc.
200,940US$1.1m-28.3%no data
0.3%
Susquehanna International Group, LLP
193,200US$1.0m1,600%no data
0.29%
Sovran Advisors, LLC
188,972US$1.0m-5.43%0.1%
0.27%
Vivaldi Capital Management LP
172,443US$914.0k210%0.12%
0.26%
UBS Asset Management AG
167,865US$889.7k221%no data
0.25%
The Retirement Guys Formula LLC
159,593US$845.8k2.74%0.28%
0.23%
Kevin Freeman
147,832US$783.5k-32.3%no data
0.23%
Millennium Management LLC
144,528US$766.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/22 00:13
End of Day Share Price 2025/10/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Galectin Therapeutics Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keay NakaeAscendiant Capital Markets LLC
Mayank MamtaniB. Riley Securities, Inc.
Antonio ArceH.C. Wainwright & Co.